Zomedica Pharmaceuticals Corp (NYSE American:ZOM)
| 0.1015 Delayed Data As of Sep 17 |  +0.0026 / +2.63%Today’s Change | 0.10 Today|||52-Week Range 0.50 | -69.34% Year-to-Date |
Latest ZOM News | Press Releases
| Zomedica to develop gastrointestinal testing panel for Truforma Sep 08 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 0.10 |
| Today’s open | 0.10 |
| Day’s range | 0.10 - 0.10 |
| Volume | 388,241 |
| Average volume (3 months) | 49,439,875 |
| Market cap | $60.6M |
Data as of 4:51pm ET, 09/17/2020
Growth & Valuation
| Earnings growth (last year) | -4.43% |
| Earnings growth (this year) | +84.21% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| REPHRecro Pharma Inc | +0.09 | +4.00% |
| SCYXSCYNEXIS Inc | -0.04 | -0.76% |
| PDSBPDS Biotechnology Co... | 0.00 | 0.00% |
| DFFNDiffusion Pharmaceut... | +0.01 | +1.19% |
Data as of 3:59pm ET, 09/17/2020
Financials
| Next reporting date | November 17, 2020 |
| EPS forecast (this quarter) | $0.00 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$19.8M |
| Net profit margin | -- |
Profile
Sector Miscellaneous |
Industry Miscellaneous |
No executives to display |
Corporate headquarters --, -- |
Forecasts
